Merck (MRK) Tops Q1 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
April 25, 2024 6:47 AM EDTMerck (NYSE: MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked its outlook for the fiscal year 2024.
For Q1 2024, Merck reported earnings per share (EPS) at $2.07, surpassing analyst expectations of $1.93. The companys revenue for the quarter was $15.8 billion,... More
Merck (MRK) call put ratio 2.6 calls to 1 put into quarter results and outlook
April 24, 2024 10:11 AM EDTMerck (NYSE: MRK) April weekly call option implied volatility is at 49, May is at 21; compared to its 52-week range of 16 to 26 into the expected release of quarter results before the bell on April 25.
... More